Atlas Trials

Observational Study to Evaluate the Effectiveness and Safety of Levemir®, NovoMix® 30 and NovoRapid® in Insulin naïve Subjects With Type 2 Diabetes

Clinical trial NCT00771680 · COMPLETED

Trial details

NCT number
NCT00771680
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Study type
OBSERVATIONAL
DiabetesDiabetes Mellitus, Type 2
Start date
2008-10-01
Primary completion
2010-07-01
Enrollment
10408

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.